Cencora announced the acquisition of American Oncology Network. It currently holds 4% of equity interest in AON, and the deal values the target at $2.4 billion. AON shareholders could participate in an equity rollover, in which case Cencora will pay $1.7 billion for 71% of AON.
Cencora distributes pharmaceutical products to nearly one-third of the industry, leading to substantial negotiation leverage with drug manufacturers.
Reimbursement pressures on pharmacy and provider customers have led to an emphasis on cost containment, pressuring Cencora's profitability.
|
Metric
|
COR
|
CAH
|
MCK
|
|---|---|---|---|
Price/Earnings (Normalized) | 19.85 | 22.87 | 24.88 |
Price/Book Value | 21.29 | — | — |
Price/Sales | 0.20 | 0.24 | 0.30 |
Price/Cash Flow | 16.78 | 17.37 | 20.22 |
|
Metric
|
COR
|
CAH
|
MCK
|
|---|---|---|---|
Quick Ratio | 0.48 | 0.43 | 0.50 |
Current Ratio | 0.93 | 0.88 | 0.89 |
Interest Coverage | 7.89 | 7.25 | 23.83 |
|
Metric
|
COR
|
CAH
|
MCK
|
|---|---|---|---|
Return on Assets (Normalized) | 4.24% | 4.62% | 5.95% |
Return on Equity (Normalized) | 141.22% | — | — |
Return on Invested Capital (Normalized) | 30.10% | 46.33% | 56.43% |
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| McKesson Corp
MCK
| LOCK|&RBCDq | LOCK|t#<# | $118B | |||
| Cardinal Health Inc
CAH
| LOCK|d$g&p&@ | LOCK|&J>N | $60B | |||
| Sigma Healthcare Ltd
SIGGF
| — | LOCK|%ZDD | $22B | |||
| Henry Schein Inc
HSIC
| LOCK|Y>Nn#c$ | LOCK|%fggZ | $9B | |||
| Shanghai Pharmaceuticals Holding Co Ltd ADR
SHPMY
| — | LOCK|K^ | $8B | |||
| Sinopharm Group Co Ltd ADR
SHTDY
| — | LOCK|bzv | $6B | |||
| Sinopharm Group Co Ltd
SHTDF
| — | LOCK|!pC | $6B | |||
| Galenica Ltd
GALNF
| — | LOCK|H$@%c | $5B | |||
| Medipal Holdings Corp
MEPDF
| — | LOCK|Vg% | $4B |
United States